AI Insight
Researchers at LMU University Hospital are developing three-dimensional brain tissue models to better study Alzheimer's disease and accelerate drug discovery. According to Professor Dominik Paquet, current research lacks 3D models that accurately replicate the complex interactions occurring in human brain tissue affected by Alzheimer's. These lab-grown tissue models aim to fill this critical gap in Alzheimer's research methodology.
Why it matters
This development could significantly speed up the discovery of effective Alzheimer's treatments by providing more accurate testing platforms that better mimic actual human brain conditions. The technology may reduce reliance on less representative models and improve the success rate of drug candidates moving from laboratory to clinical trials.
Understand the Science
How can Alzheimer’s research be made faster, better and more effective? After decades of intensive research worldwide and despite recent therapeutic advances, scientists have not managed to fully arrest the progress of the disease. “What we are still lacking is three-dimensional models that accurately replicate the complex interactions in human brain tissue with Alzheimer’s disease,” explains Dominik Paquet, professor of neurobiology at the Institute for Stroke and Dementia Research at LMU University Hospital.
Source: 3D brain tissue model recreates key Alzheimer's interactions for drug testing